130 Studies Linking Vaccines to Neurological & Autoimmune Diseases, 2017
Vaccine Excipient & Media Summary
Excipients Included in U.S. Vaccines, by Vaccine
1 Increased risk of developmental neurologic impairment after high
exposure to thimerosal-containing vaccine in first month of
Division of Epidemiology and Surveillance, Vaccine Safety
and Development Branch, National Immunization Program,
Centers for Disease Control and Prevention. 1999.
Thomas M. Verstraeten, R. Davies, D. Gu, F DeStefano
Background: Concern has risen on the presence of the
ethylmercury containing preservative thimerosal in vaccines.
We assessed the risk for neurologic and renal impairment
associated with past exposure to thimerosal-containing
vaccine using automated data from the Vaccine Safety Data
link (VSD). VSD is a large linked database from four health
maintenance organizations in Washington, Oregon and
California, containing immunization, medical visit and
demographic data on over 400,000 infants born between ’91
Methods: We categorized the cumulative ethylmercury
exposure from Thimerosal containing vaccines after one
month of life and assessed the subsequent risk of
degenerative and developmental neurologic disorders and
renal disorders before the age of six. We applied
proportional hazard models adjusting for HMO, year of birth,
and gender, excluding premature babies.
Results: We identified 286 children with degenerative and
3702 with developmental neurologic disorders, and 310 with
renal disorders. The relative risk (RR) of developing a
neurologic development disorder was 1.8 ( 95% confidence
intervals [CI] =1.1-2.8) when comparing the highest
exposure group at 1 month of age (cumulative dose> 25 ug)
2. Hepatitis B vaccination of male neonates and autism
diagnosis, NHIS 1997-2002.
4 Gallagher CM, Goodman MS.
6 J Toxicol Environ Health A. 2010;73(24):1665-77. doi:
Universal hepatitis B vaccination was recommended for U.S.
newborns in 1991; however, safety findings are mixed. The
association between hepatitis B vaccination of male
neonates and parental report of autism diagnosis was
determined. This cross-sectional study used weighted
probability samples obtained from National Health Interview
Survey 1997-2002 data sets. Vaccination status was
determined from the vaccination record. Logistic regression
was used to estimate the odds for autism diagnosis
associated with neonatal hepatitis B vaccination among boys
age 3-17 years, born before 1999, adjusted for race,
maternal education, and two-parent household. Boys
vaccinated as neonates had threefold greater odds for
autism diagnosis compared to boys never vaccinated or
vaccinated after the first month of life. Non-Hispanic
white boys were 64% less likely to have autism diagnosis
relative to nonwhite boys. Findings suggest that U.S. male
neonates vaccinated with the hepatitis B vaccine prior to
1999 (from vaccination record) had a threefold higher risk for
parental report of autism diagnosis compared to boys not
vaccinated as neonates during that same time period.
Nonwhite boys bore a greater risk.
30. Autism: a form of lead and mercury toxicity
Environ Toxicol Pharmacol. 2014 Nov;38(3):1016-24. doi:
10.1016/j.etap.2014.10.005. Epub 2014 Nov 6.
AIM: Autism is a developmental disability characterized by
severe deficits in social interaction and communication. The
definite cause of autism is still unknown. The aim of this
study is to find out the relation between exposure to Lead
and/or mercury as heavy metals and autistic symptoms,
dealing with the heavy metals with chelating agents can
improve the autistic symptoms.
METHOD: Blood and hair samples were obtained from 45
children from Upper Egypt with autism between the ages of
2 and 10 years and 45 children served as controls in the
same age range, after taken an informed consent and fill a
questionnaire to assess the risk factors. The samples were
analyzed blindly for lead and mercury by using atomic
absorption and ICP-MS. Data from the two groups were
compared, then follow up of the autistic children after
treatment with chelating agents were done.
RESULTS: The results obtained showed significant
difference among the two groups, there was high level of
mercury and lead among those kids with autism. Significant
decline in the blood level of lead and mercury with the use of
DMSA as a chelating agent. In addition, there was decline in
the autistic symptoms with the decrease in the lead and
mercury level in blood.
CONCLUSION: Lead and mercury considered as one of
the main causes of autism. Environmental exposure as
well as defect in heavy metal metabolism is responsible
for the high level of heavy metals. Detoxification by
chelating agents had great role in improvement of those
21 Do aluminum vaccine adjuvants contribute to the rising
prevalence of autism?
J Inorg Biochem. 2011 Nov;105(11):1489-99. Epub 2011 Aug
Tomljenovic L, Shaw CA.
Neural Dynamics Research Group, Department of
Ophthalmology and Visual Sciences, University of British
Columbia, 828 W. 10th Ave, Vancouver, BC, Canada V5Z
Autism spectrum disorders (ASD) are serious multisystem
developmental disorders and an urgent global public health
concern. Dysfunctional immunity and impaired brain function
are core deficits in ASD. Aluminum (Al), the most commonly
used vaccine adjuvant, is a demonstrated neurotoxin and a
strong immune stimulator. Hence, adjuvant Al has the
potential to induce neuroimmune disorders. When assessing
adjuvant toxicity in children, two key points ought to be
considered: (i) children should not be viewed as “small
adults” as their unique physiology makes them much more
vulnerable to toxic insults; and (ii) if exposure to Al from only
few vaccines can lead to cognitive impairment and
autoimmunity in adults, is it unreasonable to question
whether the current pediatric schedules, often containing 18
Al adjuvanted vaccines, are safe for children? By applying
Hill’s criteria for establishing causality between exposure and
outcome we investigated whether exposure to Al from
vaccines could be contributing to the rise in ASD prevalence
in the Western world. Our results show that: (i) children from
countries with the highest ASD prevalence appear to have
the highest exposure to Al from vaccines; (ii) the increase in
exposure to Al adjuvants significantly correlates with the
increase in ASD prevalence in the United States observed
over the last two decades (Pearson r=0.92, p<0.0001); and
(iii) a significant correlation exists between the amounts of Al
administered to preschool children and the current
prevalence of ASD in seven Western countries, particularly
at 3-4months of age (Pearson r=0.89-0.94,
p=0.0018-0.0248). The application of the Hill’s criteria to
these data indicates that the correlation between Al in
vaccines and ASD may be causal. Because children
represent a fraction of the population most at risk for
complications following exposure to Al, a more rigorous
evaluation of Al adjuvant safety seems warranted.
A nurse delivers the red-pill
Explosion of vaccine related injuries
There appears to be a war being waged across the U.S. regarding mandatory vaccination targeted at our youngest and most vulnerable and also our healthcare and childcare workers. Now there is narrative starting to be put forward that unvaccinated adults are costing the economy billions of dollars a year. This is all based on the premise, one that is repeated as a mantra by those in the medical community, that vaccines are safe and effective and that the science is settled. But what if that premise is false?
I never really questioned vaccine safety and I thought I understood the reasoning of why vaccines worked. I had been in a pre-med curriculum in my undergraduate study and my children were vaccinated in the 1980s when they were young. I was a practicing R.N. for many years and I received a number of vaccines during that time and I administered many. I was injured by the Hep B vaccine series in 1992-93, but no one was very interested in reporting or tracking that injury. I began studying vaccination in 2009 when I was out on a disability leave of absence.
There is an explosion of vaccine related injuries occurring across our country. There is something very, very wrong happening to our children; many are suffering from allergies, neurological and immune-system damage. In 1986 the National Childhood Vaccine Injury Act was passed where The National Vaccine Injury Compensation Board was formed by Congress at the bequest of the vaccine manufacturers because they were being inundated with lawsuits from parents of children that had been injured by vaccines and this was seriously effecting their profit margins. This legislation made the pharmaceutical companies and the administrators of the vaccines not liable for injuries. The onus was put on the parents of an injured children to present their case to this “Vaccine Court.” Many cases are not heard. The process can take years and many of these plaintiffs are not compensated. The taxpayer is the one that bears the financial burden of compensation for these injuries and not the pharmaceutical companies. One might ask, if there is no liability to the manufacturer or deliverer, what incentive is there to make safe vaccines backed by long trials with true control groups and preferably ones that are a double blind study? 3.6 billion dollars has been awarded due to vaccine injury since the conception of this compensation program. Dr. Alvin Moss just told us on March 18th before West Virginia’s Senate Education Committee hearing that in 2016, $250 million was awarded to 800 individuals which breaks down to around $300,000 per individual.”